• Conference Recording
  • On-Demand
  • Pharmacotherapy
This session will inform HCPs on the tirzepatide molecule, design of the SURMOUNT global trial program for the treatment of obesity and overweight, and safety and efficacy data disclosure for SURMO
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Behavioral Modification
In adolescents and adults, the co-occurrence of eating disorders and overweight or obesity is continuing to increase.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
Obesity is a complex phenotype reflecting the interactions of numerous genes that have been “selected” for in service of reproductive integrity with modern environments.
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
  • Nutrition Therapy
Intermittent Fasting (IF) as a means of dietary modification has gained popularity among individuals with obesity as a means of achieving weight loss.
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Nutrition Therapy
Individual patient response to nutritional therapies varies widely.
  • 1.25 AMA PRA Category 1 Credit
  • On-Demand
  • Behavioral Modification
Lifestyle Therapeutics in Obesity Medicine Certificate Program
  • 4.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pediatrics
  • Treatment Strategies
The AAP has comprehensively updated their recommendations regarding the disease of obesity in childhood. The incidence of obesity in childhood has not improved.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Pediatrics
  • Pharmacotherapy
Obesity pharmacotherapy often is solely equated as therapeutic use of anti-obesity medications (AOMs). In this session, two important factors in obesity pharmacotherapy will be discussed.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Special Populations
This talk will review key features of obesity pathogenesis related to genetics, the brain, and energetics.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
This session will review the relationship and underlying mechanisms between obesity and cardiovascular disease with attention to the individual variability between BMI and CV risk.
  • 1.00 AMA PRA Category 1 Credit

Pages